Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 91 AL 105

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

Dionisio-Santos DA, Olschowka JA, O'Banion MK.

J Neuroinflammation. 2019 Apr 5;16(1):74. doi: 10.1186/s12974-019-1453-0.

Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease

Ozben T, Ozben S.

Clin Biochem. 2019 Oct;72:87-89. doi: 10.1016/j.clinbiochem.2019.04.001. Epub 2019 Apr 4.

Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?

De Simone A, Milelli A.

ChemMedChem. 2019 Jun 5;14(11):1067-1073. doi: 10.1002/cmdc.201900174. Epub 2019 May 2.

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy

Tosi G, Pederzoli F, Belletti D, Vandelli MA, Forni F, Duskey JT, Ruozi B.

Prog Brain Res. 2019;245:57-88. doi: 10.1016/bs.pbr.2019.03.001. Epub 2019 Apr 2.

Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease

Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA.

Curr Alzheimer Res. 2019;16(10):871-894. doi: 10.2174/1570159X17666190409144558.

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH.

Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11.

Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

Manolopoulos A, Andreadis P, Malandris K, Avgerinos I, Karagiannis T, Kapogiannis D, Tsolaki M, Tsapas A, Bekiari E.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):281-289. doi: 10.1177/1533317519843720. Epub 2019 Apr 15.

Effect of genetic polymorphisms on Alzheimer's disease treatment outcomes: an update

Sumirtanurdin R, Thalib AY, Cantona K, Abdulah R.

Clin Interv Aging. 2019 Mar 29;14:631-642. doi: 10.2147/CIA.S200109. eCollection 2019.

Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia

Soobiah C, Tadrous M, Knowles S, Blondal E, Ashoor HM, Ghassemi M, Khan PA, Ho J, Tricco AC, Straus SE.

PLoS One. 2019 Apr 18;14(4):e0215225. doi: 10.1371/journal.pone.0215225. eCollection 2019.

Non-conventional compounds with potential therapeutic effects against Alzheimer's disease

de Castro AA, Soares FV, Pereira AF, Polisel DA, Caetano MS, Leal DHS, da Cunha EFF, Nepovimova E, Kuca K, Ramalho TC.

Expert Rev Neurother. 2019 May;19(5):375-395. doi: 10.1080/14737175.2019.1608823. Epub 2019 Apr 29.

Effects of an Interdisciplinary Care Team on the Management of Alzheimer's Disease in China

Chen C, Huang Y, Liu C, Xu Y, Zheng L, Li J.

J Gerontol Nurs. 2019 May 1;45(5):39-45. doi: 10.3928/00989134-20190318-01.

Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease: A Meta-Analysis

Cai M, Guo Z, Xing G, Peng H, Zhou L, Chen H, McClure MA, He L, Xiong L, He B, Du F, Mu Q.

Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):170-178. doi: 10.1097/WAD.0000000000000304.

The Y(682)ENPTY(687) motif of APP: Progress and insights toward a targeted therapy for Alzheimer's disease patients

Matrone C, Iannuzzi F, Annunziato L.

Ageing Res Rev. 2019 Jul;52:120-128. doi: 10.1016/j.arr.2019.04.003. Epub 2019 Apr 27.

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer's disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim JE, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Alzheimers Res Ther. 2019 May 1;11(1):37. doi: 10.1186/s13195-019-0492-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias